Cargando…

Biventricular Increases in Mitochondrial Fission Mediator (MiD51) and Proglycolytic Pyruvate Kinase (PKM2) Isoform in Experimental Group 2 Pulmonary Hypertension-Novel Mitochondrial Abnormalities

Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25 mmHg with elevated pulmonary capillary wedge pressure >15 mmHg, has no approved therapy and patients often die from right ventricular failure (RVF). Alterations in mitochondrial metabolism, notabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Ping Yu, Tian, Lian, Dunham-Snary, Kimberly J., Chen, Kuang-Hueih, Mewburn, Jeffrey D., Neuber-Hess, Monica, Martin, Ashley, Dasgupta, Asish, Potus, Francois, Archer, Stephen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355690/
https://www.ncbi.nlm.nih.gov/pubmed/30740395
http://dx.doi.org/10.3389/fcvm.2018.00195
_version_ 1783391364907532288
author Xiong, Ping Yu
Tian, Lian
Dunham-Snary, Kimberly J.
Chen, Kuang-Hueih
Mewburn, Jeffrey D.
Neuber-Hess, Monica
Martin, Ashley
Dasgupta, Asish
Potus, Francois
Archer, Stephen L.
author_facet Xiong, Ping Yu
Tian, Lian
Dunham-Snary, Kimberly J.
Chen, Kuang-Hueih
Mewburn, Jeffrey D.
Neuber-Hess, Monica
Martin, Ashley
Dasgupta, Asish
Potus, Francois
Archer, Stephen L.
author_sort Xiong, Ping Yu
collection PubMed
description Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25 mmHg with elevated pulmonary capillary wedge pressure >15 mmHg, has no approved therapy and patients often die from right ventricular failure (RVF). Alterations in mitochondrial metabolism, notably impaired glucose oxidation, and increased mitochondrial fission, contribute to right ventricle (RV) dysfunction in PH. We hypothesized that the impairment of RV and left ventricular (LV) function in group 2 PH results in part from a proglycolytic isoform switch from pyruvate kinase muscle (PKM) isoform 1 to 2 and from increased mitochondrial fission, due either to upregulation of expression of dynamin-related protein 1 (Drp1) or its binding partners, mitochondrial dynamics protein of 49 or 51 kDa (MiD49 or 51). Methods and Results: Group 2 PH was induced by supra-coronary aortic banding (SAB) in 5-week old male Sprague Dawley rats. Four weeks post SAB, echocardiography showed marked reduction of tricuspid annular plane systolic excursion (2.9 ± 0.1 vs. 4.0 ± 0.1 mm) and pulmonary artery acceleration time (24.3 ± 0.9 vs. 35.4 ± 1.8 ms) in SAB vs. sham rats. Nine weeks post SAB, left and right heart catheterization showed significant biventricular increases in end systolic and diastolic pressure in SAB vs. sham rats (LV: 226 ± 15 vs. 103 ± 5 mmHg, 34 ± 5 vs. 7 ± 1 mmHg; RV: 40 ± 4 vs. 22 ± 1 mmHg, and 4.7 ± 1.5 vs. 0.9 ± 0.5 mmHg, respectively). Picrosirius red staining showed marked biventricular fibrosis in SAB rats. There was increased muscularization of small pulmonary arteries in SAB rats. Confocal microscopy showed biventricular mitochondrial depolarization and fragmentation in SAB vs. sham cardiomyocytes. Transmission electron microscopy confirmed a marked biventricular reduction in mitochondria size in SAB hearts. Immunoblot showed marked biventricular increase in PKM2/PKM1 and MiD51 expression. Mitofusin 2 and mitochondrial pyruvate carrier 1 were increased in SAB LVs. Conclusions: SAB caused group 2 PH. Impaired RV function and RV fibrosis were associated with increases in mitochondrial fission and expression of MiD51 and PKM2. While these changes would be expected to promote increased production of reactive oxygen species and a glycolytic shift in metabolism, further study is required to determine the functional consequences of these newly described mitochondrial abnormalities.
format Online
Article
Text
id pubmed-6355690
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63556902019-02-08 Biventricular Increases in Mitochondrial Fission Mediator (MiD51) and Proglycolytic Pyruvate Kinase (PKM2) Isoform in Experimental Group 2 Pulmonary Hypertension-Novel Mitochondrial Abnormalities Xiong, Ping Yu Tian, Lian Dunham-Snary, Kimberly J. Chen, Kuang-Hueih Mewburn, Jeffrey D. Neuber-Hess, Monica Martin, Ashley Dasgupta, Asish Potus, Francois Archer, Stephen L. Front Cardiovasc Med Cardiovascular Medicine Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25 mmHg with elevated pulmonary capillary wedge pressure >15 mmHg, has no approved therapy and patients often die from right ventricular failure (RVF). Alterations in mitochondrial metabolism, notably impaired glucose oxidation, and increased mitochondrial fission, contribute to right ventricle (RV) dysfunction in PH. We hypothesized that the impairment of RV and left ventricular (LV) function in group 2 PH results in part from a proglycolytic isoform switch from pyruvate kinase muscle (PKM) isoform 1 to 2 and from increased mitochondrial fission, due either to upregulation of expression of dynamin-related protein 1 (Drp1) or its binding partners, mitochondrial dynamics protein of 49 or 51 kDa (MiD49 or 51). Methods and Results: Group 2 PH was induced by supra-coronary aortic banding (SAB) in 5-week old male Sprague Dawley rats. Four weeks post SAB, echocardiography showed marked reduction of tricuspid annular plane systolic excursion (2.9 ± 0.1 vs. 4.0 ± 0.1 mm) and pulmonary artery acceleration time (24.3 ± 0.9 vs. 35.4 ± 1.8 ms) in SAB vs. sham rats. Nine weeks post SAB, left and right heart catheterization showed significant biventricular increases in end systolic and diastolic pressure in SAB vs. sham rats (LV: 226 ± 15 vs. 103 ± 5 mmHg, 34 ± 5 vs. 7 ± 1 mmHg; RV: 40 ± 4 vs. 22 ± 1 mmHg, and 4.7 ± 1.5 vs. 0.9 ± 0.5 mmHg, respectively). Picrosirius red staining showed marked biventricular fibrosis in SAB rats. There was increased muscularization of small pulmonary arteries in SAB rats. Confocal microscopy showed biventricular mitochondrial depolarization and fragmentation in SAB vs. sham cardiomyocytes. Transmission electron microscopy confirmed a marked biventricular reduction in mitochondria size in SAB hearts. Immunoblot showed marked biventricular increase in PKM2/PKM1 and MiD51 expression. Mitofusin 2 and mitochondrial pyruvate carrier 1 were increased in SAB LVs. Conclusions: SAB caused group 2 PH. Impaired RV function and RV fibrosis were associated with increases in mitochondrial fission and expression of MiD51 and PKM2. While these changes would be expected to promote increased production of reactive oxygen species and a glycolytic shift in metabolism, further study is required to determine the functional consequences of these newly described mitochondrial abnormalities. Frontiers Media S.A. 2019-01-25 /pmc/articles/PMC6355690/ /pubmed/30740395 http://dx.doi.org/10.3389/fcvm.2018.00195 Text en Copyright © 2019 Xiong, Tian, Dunham-Snary, Chen, Mewburn, Neuber-Hess, Martin, Dasgupta, Potus and Archer. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Xiong, Ping Yu
Tian, Lian
Dunham-Snary, Kimberly J.
Chen, Kuang-Hueih
Mewburn, Jeffrey D.
Neuber-Hess, Monica
Martin, Ashley
Dasgupta, Asish
Potus, Francois
Archer, Stephen L.
Biventricular Increases in Mitochondrial Fission Mediator (MiD51) and Proglycolytic Pyruvate Kinase (PKM2) Isoform in Experimental Group 2 Pulmonary Hypertension-Novel Mitochondrial Abnormalities
title Biventricular Increases in Mitochondrial Fission Mediator (MiD51) and Proglycolytic Pyruvate Kinase (PKM2) Isoform in Experimental Group 2 Pulmonary Hypertension-Novel Mitochondrial Abnormalities
title_full Biventricular Increases in Mitochondrial Fission Mediator (MiD51) and Proglycolytic Pyruvate Kinase (PKM2) Isoform in Experimental Group 2 Pulmonary Hypertension-Novel Mitochondrial Abnormalities
title_fullStr Biventricular Increases in Mitochondrial Fission Mediator (MiD51) and Proglycolytic Pyruvate Kinase (PKM2) Isoform in Experimental Group 2 Pulmonary Hypertension-Novel Mitochondrial Abnormalities
title_full_unstemmed Biventricular Increases in Mitochondrial Fission Mediator (MiD51) and Proglycolytic Pyruvate Kinase (PKM2) Isoform in Experimental Group 2 Pulmonary Hypertension-Novel Mitochondrial Abnormalities
title_short Biventricular Increases in Mitochondrial Fission Mediator (MiD51) and Proglycolytic Pyruvate Kinase (PKM2) Isoform in Experimental Group 2 Pulmonary Hypertension-Novel Mitochondrial Abnormalities
title_sort biventricular increases in mitochondrial fission mediator (mid51) and proglycolytic pyruvate kinase (pkm2) isoform in experimental group 2 pulmonary hypertension-novel mitochondrial abnormalities
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355690/
https://www.ncbi.nlm.nih.gov/pubmed/30740395
http://dx.doi.org/10.3389/fcvm.2018.00195
work_keys_str_mv AT xiongpingyu biventricularincreasesinmitochondrialfissionmediatormid51andproglycolyticpyruvatekinasepkm2isoforminexperimentalgroup2pulmonaryhypertensionnovelmitochondrialabnormalities
AT tianlian biventricularincreasesinmitochondrialfissionmediatormid51andproglycolyticpyruvatekinasepkm2isoforminexperimentalgroup2pulmonaryhypertensionnovelmitochondrialabnormalities
AT dunhamsnarykimberlyj biventricularincreasesinmitochondrialfissionmediatormid51andproglycolyticpyruvatekinasepkm2isoforminexperimentalgroup2pulmonaryhypertensionnovelmitochondrialabnormalities
AT chenkuanghueih biventricularincreasesinmitochondrialfissionmediatormid51andproglycolyticpyruvatekinasepkm2isoforminexperimentalgroup2pulmonaryhypertensionnovelmitochondrialabnormalities
AT mewburnjeffreyd biventricularincreasesinmitochondrialfissionmediatormid51andproglycolyticpyruvatekinasepkm2isoforminexperimentalgroup2pulmonaryhypertensionnovelmitochondrialabnormalities
AT neuberhessmonica biventricularincreasesinmitochondrialfissionmediatormid51andproglycolyticpyruvatekinasepkm2isoforminexperimentalgroup2pulmonaryhypertensionnovelmitochondrialabnormalities
AT martinashley biventricularincreasesinmitochondrialfissionmediatormid51andproglycolyticpyruvatekinasepkm2isoforminexperimentalgroup2pulmonaryhypertensionnovelmitochondrialabnormalities
AT dasguptaasish biventricularincreasesinmitochondrialfissionmediatormid51andproglycolyticpyruvatekinasepkm2isoforminexperimentalgroup2pulmonaryhypertensionnovelmitochondrialabnormalities
AT potusfrancois biventricularincreasesinmitochondrialfissionmediatormid51andproglycolyticpyruvatekinasepkm2isoforminexperimentalgroup2pulmonaryhypertensionnovelmitochondrialabnormalities
AT archerstephenl biventricularincreasesinmitochondrialfissionmediatormid51andproglycolyticpyruvatekinasepkm2isoforminexperimentalgroup2pulmonaryhypertensionnovelmitochondrialabnormalities